We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Octopus Group

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Revolutionary, Non-Invasive Technique Measures Glucose Levels Without Drawing Blood

By LabMedica International staff writers
Posted on 24 Nov 2022
Print article
Image: EM-based subcutaneous implant glucose sensor (Photo courtesy of UNIST)
Image: EM-based subcutaneous implant glucose sensor (Photo courtesy of UNIST)

More than 400 million people worldwide are living with diabetes and they still suffer from pricking their fingers multiple times a day to check their blood glucose levels. One of the main aims of diabetes treatment is to keep blood glucose levels within a specified target range. Diabetes can be diagnosed if fasting blood glucose levels are 126 mg/dL or higher. A normal fasting glucose test result is lower than 100 mg/dL. Various methods alternate to finger-pricking method have been extensively studied for blood glucose detection, such as enzyme-based or optical-based glucose sensor. However, they still have issues in terms of long lifetime, portability, and accuracy. Now, a recent study has reported a new route for measuring blood sugar levels (BGLs) without drawing blood.

In a recent study affiliated with UNIST (Ulsan, Korea), researchers have demonstrated a revolutionary, non-invasive technique for testing blood glucose levels, using electromagnetic (EM)-wave-based glucose sensor inserted under the skin. Their findings have attracted much attention, as it eliminates the need for patients with diabetes to constantly prick their fingers with a glucose meter. In the study, the research team proposed a electromagnetic-based sensor that can be subcutaneously implanted and is capable of tracking minute changes in dielectric permittivity owing to changes in BGLs. The proposed sensor, which is about one-fifth of a cotton swab, can measure changes in glucose concentrations in interstitial fluid (ISF), the liquid that fills spaces between cells.

In the study, the research team demonstrated semi-permanent and continuous blood sugar management at low maintenance costs without the pain caused by blood collection, enabling patients to enjoy quality life through proper treatment and management of diabetes. This is expected to increase the use of CGMS, which currently stands at only 5%. The research team also performed both the intravenous glucose tolerance test (IVGTT) and oral glucose tolerance test (OGTT) with the sensor implanted to swine and beagle in a controlled environment. The results of initial proof-of-concept in vivo experiment showed promising correlation between BGL and sensor frequency response, according to the research team.

“Present work is an effort for the realization of implantable electromagnetic-based sensor, which can be an alternate to enzyme-based or optical-based glucose sensor,” noted the research team. ‘The proposed implantable sensor has not only overcome the disadvantages of the existing continuous glucose monitoring systems (CGMS), such as short lifespan, but has also enhanced the blood glucose prediction accuracy.”

“Our proposed sensor and system are indeed in the early stage of development,” noted the research team. “Despite that, the proof-of-concept in vivo results show promising correlation between BGL and sensor frequency response. Indeed, the sensor shows the ability to track BGL trend.”

“For actual sensor implantation we must consider bio compatible packaging and foreign body reactions (FBR) for long term applications. In addition, improved sensor interface system is under development,” added the research team.

Related Links:
UNIST

New
Gold Supplier
Group A Streptococcus Antigen Test
OSOM Strep A Test
New
Lab Incubator
IN-010
New
TSH (Thyroid Stimulating Hormone) Test
Kemilo TSH Kit
New
Silver Supplier
Real-Time PCR Thermal Cycler
Eonis Q96

Print article

Channels

Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more

Immunology

view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more

Microbiology

view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more

Pathology

view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more

Industry

view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.